Virtu Financial LLC Takes $263,000 Position in Privia Health Group, Inc. (NASDAQ:PRVA)

Virtu Financial LLC acquired a new position in shares of Privia Health Group, Inc. (NASDAQ:PRVA) in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 14,469 shares of the company’s stock, valued at approximately $263,000.

Other large investors have also bought and sold shares of the company. Victory Capital Management Inc. lifted its holdings in shares of Privia Health Group by 402.9% in the third quarter. Victory Capital Management Inc. now owns 179,049 shares of the company’s stock worth $3,260,000 after acquiring an additional 143,446 shares during the last quarter. GAMMA Investing LLC lifted its stake in Privia Health Group by 98.7% in the 3rd quarter. GAMMA Investing LLC now owns 1,701 shares of the company’s stock valued at $31,000 after purchasing an additional 845 shares during the last quarter. Dynamic Technology Lab Private Ltd bought a new position in Privia Health Group in the 3rd quarter valued at approximately $1,206,000. Peregrine Capital Management LLC boosted its position in Privia Health Group by 11.5% in the second quarter. Peregrine Capital Management LLC now owns 314,190 shares of the company’s stock valued at $5,461,000 after buying an additional 32,311 shares in the last quarter. Finally, BlackBarn Capital Partners LP grew its stake in shares of Privia Health Group by 100.0% during the second quarter. BlackBarn Capital Partners LP now owns 400,000 shares of the company’s stock worth $6,952,000 after buying an additional 200,000 shares during the last quarter. 94.48% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

PRVA has been the topic of several recent research reports. KeyCorp assumed coverage on Privia Health Group in a report on Friday, October 11th. They set an “overweight” rating and a $23.00 price objective on the stock. Macquarie initiated coverage on Privia Health Group in a report on Monday. They set an “outperform” rating and a $25.00 price target on the stock. Barclays upped their price objective on Privia Health Group from $19.00 to $21.00 and gave the company an “equal weight” rating in a research note on Friday, November 8th. Robert W. Baird lifted their target price on shares of Privia Health Group from $23.00 to $24.00 and gave the stock an “outperform” rating in a research report on Monday, August 26th. Finally, JPMorgan Chase & Co. upped their price target on shares of Privia Health Group from $27.00 to $28.00 and gave the company an “overweight” rating in a research report on Friday, November 29th. Two analysts have rated the stock with a hold rating, twelve have given a buy rating and two have assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Buy” and a consensus price target of $24.80.

Privia Health Group Trading Down 4.9 %

Shares of Privia Health Group stock opened at $20.79 on Wednesday. The business has a 50-day moving average price of $20.12 and a two-hundred day moving average price of $19.10. Privia Health Group, Inc. has a 1-year low of $15.92 and a 1-year high of $24.30. The company has a market cap of $2.49 billion, a P/E ratio of 207.92, a PEG ratio of 5.45 and a beta of 0.83.

Privia Health Group Company Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.